Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Digital Brands Group Added to S&P Total Market Index (TMI)
-
QHSLab, Inc. (OTCQB:USAQ) Completes $500K Private Placement, Enters 2026 With Clean Capital Structure
-
Digital Brands Group Added to S&P Total Market Index (TMI)
-
Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta
-
IPDN Announces Strategic Investment in DeeptradeX.AI Platform Token DTT Valued at US$2.59 Million
-
IP Strategy Cancels $15 Million ELOC, Reinforcing Balance Sheet Strength and Reducing Related Dilution Risk
-
Tron Inc. Secures $18 Million Strategic Investment from Justin Sun, Founder of the TRON Blockchain
-
Alico to Participate at 28th Annual ICR Conference
-
Reliance Global Group Completes Strategic Sale of its EBS / USBA Business Unit
-
TechForce Robotics Announces Manufacturing Scale Strategy to Support Accelerating Demand
-
The Better Brain Company’s Dementia Prevention Expert Dr. Clint Steele Releases “101 Brain Hacks To Prevent and Even Reverse Dementia”
-
N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy
-
MEDIROM Partners with World on Technology Envisioned by Sam Altman and Alex Blania: Deploying “Proof of Human” Infrastructure throughout Japan
-
Foresight Selected by Car Manufacturer Audi AG to Showcase its Terrain Intelligence Technology
-
Syntiant Expands NDP115 Portfolio with New eWLB and Ultra-Thin Packages, Bringing Advanced Edge AI to Ultra-Compact Devices
-
Genmab Portfolio Prioritization Update
-
Compass Diversified Reports Second Quarter 2025 Financial Results
-
Core AI Announces Divestiture of Siyata Mobile and Subsidiaries
-
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State
-
MedBright AI Investments Inc. Announces Name Change and Amended Investment Policy
-
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor
-
Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
-
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
-
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)
-
Rezolve Ai Unveils New SQD Revenue Model Backed by Enterprise Customers
-
Tokyo Lifestyle Co., Ltd. Issues 2026 Chairman’s Letter to Shareholders
-
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
-
VCI Global Signs Binding Term Sheet to Acquire Controlling 51% Stake in RTCAR Mexico, Secures Tier-1 Production Hub for Global Automotive Giant’s North American Expansion
-
NIP Group Inc. Announces Results of Extraordinary General Meeting
-
CareCloud Appoints Chief Strategy Officer to Lead Enterprise AI Platform as Company Enters 2026 as Its Defining AI Year
-
CCH Holdings Projects Multiple Acquisitions, New Business Ventures and International Expansion in 2026
-
LC Sign Scales Bespoke Signage Manufacturing Through Project-Driven Excellence
-
Kratos Receives Approximately $30 Million in Air Defense and C5ISR System National-Security-Related Hardware Production Contracts
-
Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Festi hf.: Announcement from the Nomination Committee of Festi hf.
-
BiomX Announces $3.0 Million Private Placement
-
Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering
-
Datavault AI Inc. Announces Proposed Dividend of Warrants
-
Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
-
Fusion Fuel’s BrightHy Solutions Signs Agreements to Launch Up to €30 Million Targeted Hydrogen Investment Platform
-
KH Group Plc - Managers' Transactions – Juha Karttunen
-
AZX, an Oder Book DEX, Debuts Beta Testing with Breakthrough Performance and Innovation
-
AZX, an Oder Book DEX, Debuts Beta Testing with Breakthrough Performance and Innovation
-
Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights
-
Fastsættelse af rentekupon - SNP 2029 (SEK)
-
Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)
-
illumin Announces TSX Acceptance of Normal Course Issuer Bid
-
Polyrizon to Explore Revenue-Generating Real Asset Opportunities, Leveraging Strong Cash Position and Debt-Free Balance Sheet
-
Biptap Sets the Stage for Omnibanking in 2026
-
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
